Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis

p.R165P patients progress to a less disabling disease state than typical FRDA. Comorbid hemochromatosis may worsen FRDA symptoms through additive effects on iron metabolism.